Diana Isaacs

Hello and welcome to another episode of Diabetes Dialogue, Technology, Therapeutics, and Real-World Perspectives.

My name is Diana Isaacs.

I am joined with my co-host, Natalie Bellini, and we have another exciting update.

This is a brand new podcast.

Hello, and welcome to another episode of Diabetes Dialogue, Technology, Therapeutics, and Real World Perspectives.

My name is Diana Isaacs.

I am joined with my co-host, Natalie Bellini, and we had to get on and do a special episode related to beta bionics updates.

Wow.

Welcome to a brand new series of ATTD Diabetes Talks.

My name is Diana Isaacs, and I'm an endocrine clinical pharmacy specialist at the Cleveland Clinic, and I'm the host of this new series, The Power of Weekly Insulin, supported by Eli Lilly and Company.

In today's episode, we want to explore the weekly insulin breakthrough, including the evolution of basal insulin therapies, pharmacokinetics, and unique benefits of weekly insulin, and the role of weekly insulin in modern diabetes care.

To help me in this discussion, I'm delighted to be joined by Dr. Rudolfo Galindo, Associate Professor of Medicine and Director of Comprehensive Diabetes Center at University of Miami Health System.

Hello, and welcome to another episode of Diabetes Dialogue: Technology, Therapeutics, and Real World Perspectives.

My name is Diana Isaacs.

I am joined with my co-host, Natalie Bellini, and we have a special episode with a special guest.

I'm very excited to have Casey Halpern on from Sync Neuro.

I'm your host, Patrick McMahon.

Today, we are joined by two nationally recognized experts in diabetes technology and clinical care, Dr. Diana Isaacs and Dr. Earl Hirsch.

Together, they're the authors of a recently published paper, Clinical Approaches to Managing Glycemia with the iLet Dosing Decision Software in the journal Diabetes Technology & Obesity.

You can find this paper in the show notes of this episode.

Dr. Isaacs and Dr. Hirsch, can you please introduce yourselves to our listeners and why it's important to write this paper now?

Thank you so much for having me here today.

Uh, my name is Diana Isaacs.

I'm an endocrine pharmacist at Cleveland Clinic.

Hello, and welcome to another episode of Diabetes Dialogue, Technology, Therapeutics, and Real World Perspectives.

My name is Diana Isaacs.

I am joined with my co-host, Natalie Bellini.

And in this episode, we actually want to talk a little bit about insulin.